Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05675501 · ClinicalTrials.gov registry record · Phase 1
Evaluation of Topical Encapsulated Benzoyl Peroxide on the Skin Microbiome and Skin Biophysical Properties
A Phase 1 study of Papulopustular Rosacea, sponsored by Sol-Gel Technologies.
- Completed
- Registry status
- Phase 1
- Development phase
- 31
- Enrollment target
- 1
- Study location
NCT05675501: Completed Phase 1 study of Papulopustular Rosacea, sponsored by Sol-Gel Technologies.
NCT05675501 is a Phase 1 study of Papulopustular Rosacea that has completed, run by Sol-Gel Technologies. The registered enrollment target is 31 participants, below the 277-participant average among 11 other Papulopustular Rosacea trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05675501, a Phase 1 study of Papulopustular Rosacea, has completed, sponsored by Sol-Gel Technologies.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall objective of this study is to assess how the use of the drug may shift the skin microbiome and skin biophysical properties. Specifically, the study objectives were to assess the following: * How the drug affects the skin microbiome compared with vehicle when applied once daily for 8 weeks in subjects with papulopustular rosacea. * How the drug affects the skin physical properties compared with vehicle when applied once daily for 8 weeks in subjects with papulopustular rosacea.
Primary Outcome
Facial microbiome sampling will be performed on-site by collecting follicular samples as well as utilizing facial swabs.
Conditions Studied
Interventions
- DRUG Encapsulated Benzoyl Peroxide Cream
Study Locations (1)
California
- Integrative Skin Science and Research (ISSR) - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2020-06-10 |
| Est. Completion | 2021-07-15 |
| Phase | Phase 1 |
What the finished NCT05675501 record still lists
NCT05675501 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 277-participant average among 11 other Papulopustular Rosacea trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Papulopustular Rosacea appearing as the primary indexed condition, and to 1 intervention - of which Encapsulated Benzoyl Peroxide Cream is the first listed.
NCT05675501 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05675501 about?
NCT05675501 is a clinical study titled "Evaluation of Topical Encapsulated Benzoyl Peroxide on the Skin Microbiome and Skin Biophysical Properties". The overall objective of this study is to assess how the use of the drug may shift the skin microbiome and skin biophysical properties. Specifically, the study objectives were to assess the following: * How the drug affects the skin microbiome compared with vehicle when applied once daily for 8 wee...
What is the current status of trial NCT05675501?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 31 participants. The study started on 2020-06-10. Estimated completion is 2021-07-15.
What conditions does trial NCT05675501 study?
This clinical trial studies the following conditions: Papulopustular Rosacea.
What interventions are being tested in trial NCT05675501?
The interventions under investigation include: Encapsulated Benzoyl Peroxide Cream (DRUG).
Who is sponsoring clinical trial NCT05675501?
This trial is sponsored by Sol-Gel Technologies, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05675501 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Papulopustular Rosacea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05675501's enrollment target sits among peer trials
31 8th of 11 higher than 4 of 11 other Papulopustular Rosacea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Papulopustular Rosacea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
An Analysis of the Effect of Topical Cromolyn Sodium on Rosacea-associated Erythema
COMPLETED · Phase 1
-
Efficacy and Safety of Topical Clascoterone (WINLEVI) Cream 1% in Patients With Facial Acneiform Rosacea
RECRUITING · Phase 2
-
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
COMPLETED · Phase 3
-
Excel V 532 nm KTP Laser for Treatment of Erythematotelangiectatic Rosacea & Papulopustular Rosacea
COMPLETED · NA
-
Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experience on Oracea
COMPLETED · Phase 4
-
A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea.
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI